BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 19888339)

  • 1. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.
    Bossart KN; Zhu Z; Middleton D; Klippel J; Crameri G; Bingham J; McEachern JA; Green D; Hancock TJ; Chan YP; Hickey AC; Dimitrov DS; Wang LF; Broder CC
    PLoS Pathog; 2009 Oct; 5(10):e1000642. PubMed ID: 19888339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.
    Geisbert TW; Mire CE; Geisbert JB; Chan YP; Agans KN; Feldmann F; Fenton KA; Zhu Z; Dimitrov DS; Scott DP; Bossart KN; Feldmann H; Broder CC
    Sci Transl Med; 2014 Jun; 6(242):242ra82. PubMed ID: 24964990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection.
    Mire CE; Chan YP; Borisevich V; Cross RW; Yan L; Agans KN; Dang HV; Veesler D; Fenton KA; Geisbert TW; Broder CC
    J Infect Dis; 2020 May; 221(Suppl 4):S471-S479. PubMed ID: 31686101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.
    Pallister JA; Klein R; Arkinstall R; Haining J; Long F; White JR; Payne J; Feng YR; Wang LF; Broder CC; Middleton D
    Virol J; 2013 Jul; 10():237. PubMed ID: 23867060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease.
    Prescott J; DeBuysscher BL; Feldmann F; Gardner DJ; Haddock E; Martellaro C; Scott D; Feldmann H
    Vaccine; 2015 Jun; 33(24):2823-9. PubMed ID: 25865472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nipah virus: vaccination and passive protection studies in a hamster model.
    Guillaume V; Contamin H; Loth P; Georges-Courbot MC; Lefeuvre A; Marianneau P; Chua KB; Lam SK; Buckland R; Deubel V; Wild TF
    J Virol; 2004 Jan; 78(2):834-40. PubMed ID: 14694115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization strategies against henipaviruses.
    Broder CC; Geisbert TW; Xu K; Nikolov DB; Wang LF; Middleton D; Pallister J; Bossart KN
    Curr Top Microbiol Immunol; 2012; 359():197-223. PubMed ID: 22481140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets.
    Satterfield BA; Cross RW; Fenton KA; Borisevich V; Agans KN; Deer DJ; Graber J; Basler CF; Geisbert TW; Mire CE
    J Virol; 2016 Jul; 90(14):6326-6343. PubMed ID: 27147733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.
    Mire CE; Versteeg KM; Cross RW; Agans KN; Fenton KA; Whitt MA; Geisbert TW
    Virol J; 2013 Dec; 10():353. PubMed ID: 24330654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge.
    Pallister J; Middleton D; Wang LF; Klein R; Haining J; Robinson R; Yamada M; White J; Payne J; Feng YR; Chan YP; Broder CC
    Vaccine; 2011 Aug; 29(34):5623-30. PubMed ID: 21689706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.
    DeBuysscher BL; Scott D; Marzi A; Prescott J; Feldmann H
    Vaccine; 2014 May; 32(22):2637-44. PubMed ID: 24631094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the binding interface between monoclonal antibody m102.4 and Nipah attachment glycoprotein using structure-guided alanine scanning and computational docking.
    Tit-Oon P; Tharakaraman K; Artpradit C; Godavarthi A; Sungkeeree P; Sasisekharan V; Kerdwong J; Miller NL; Mahajan B; Khongmanee A; Ruchirawat M; Sasisekharan R; Fuangthong M
    Sci Rep; 2020 Oct; 10(1):18256. PubMed ID: 33106487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.
    Yoneda M; Georges-Courbot MC; Ikeda F; Ishii M; Nagata N; Jacquot F; Raoul H; Sato H; Kai C
    PLoS One; 2013; 8(3):e58414. PubMed ID: 23516477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities.
    Nie J; Liu L; Wang Q; Chen R; Ning T; Liu Q; Huang W; Wang Y
    Emerg Microbes Infect; 2019; 8(1):272-281. PubMed ID: 30866781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Henipavirus pathogenesis and antiviral approaches.
    Mathieu C; Horvat B
    Expert Rev Anti Infect Ther; 2015 Mar; 13(3):343-54. PubMed ID: 25634624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.
    Bossart KN; Geisbert TW; Feldmann H; Zhu Z; Feldmann F; Geisbert JB; Yan L; Feng YR; Brining D; Scott D; Wang Y; Dimitrov AS; Callison J; Chan YP; Hickey AC; Dimitrov DS; Broder CC; Rockx B
    Sci Transl Med; 2011 Oct; 3(105):105ra103. PubMed ID: 22013123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroquine administration does not prevent Nipah virus infection and disease in ferrets.
    Pallister J; Middleton D; Crameri G; Yamada M; Klein R; Hancock TJ; Foord A; Shiell B; Michalski W; Broder CC; Wang LF
    J Virol; 2009 Nov; 83(22):11979-82. PubMed ID: 19759137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.
    Bossart KN; Rockx B; Feldmann F; Brining D; Scott D; LaCasse R; Geisbert JB; Feng YR; Chan YP; Hickey AC; Broder CC; Feldmann H; Geisbert TW
    Sci Transl Med; 2012 Aug; 4(146):146ra107. PubMed ID: 22875827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I interferon signaling protects mice from lethal henipavirus infection.
    Dhondt KP; Mathieu C; Chalons M; Reynaud JM; Vallve A; Raoul H; Horvat B
    J Infect Dis; 2013 Jan; 207(1):142-51. PubMed ID: 23089589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A treatment for and vaccine against the deadly Hendra and Nipah viruses.
    Broder CC; Xu K; Nikolov DB; Zhu Z; Dimitrov DS; Middleton D; Pallister J; Geisbert TW; Bossart KN; Wang LF
    Antiviral Res; 2013 Oct; 100(1):8-13. PubMed ID: 23838047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.